References
1. Kobashi Y, Mouri K, Obase Y, Fukuda M, Miyashita N, Oka M. Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients.European Respiratory Journal . 2007;30(5):945-950. doi:10.1183/09031936.00040007
2. Ryu MR, Park MS, Cho EH, et al. Comparative Evaluation of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus in Diagnosis of Latent Tuberculosis Infection in Immunocompromised Patients.Journal of Clinical Microbiology . 56(11):e00438-18. doi:10.1128/JCM.00438-18
3. Hannah HA, Miramontes R, Gandhi NR. Sociodemographic and Clinical Risk Factors Associated With Tuberculosis Mortality in the United States, 2009-2013. Public Health Rep . 2017;132(3):366-375. doi:10.1177/0033354917698117
4. Schwartz NG, Price SF, Pratt RH, Langer AJ. Tuberculosis - United States, 2019. MMWR Morb Mortal Wkly Rep . 2020;69(11):286-289. doi:10.15585/mmwr.mm6911a3
5. The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling. Accessed September 16, 2021. https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002152
6. Churchyard G, Kim P, Shah NS, et al. What We Know About Tuberculosis Transmission: An Overview. The Journal of Infectious Diseases . 2017;216(suppl_6):S629-S635. doi:10.1093/infdis/jix362
7. Corticosteroids and immunosuppressive therapy influence the result of QuantiFERON TB Gold testing in inflammatory bowel disease patients | Journal of Crohn’s and Colitis | Oxford Academic. Accessed September 16, 2021. https://academic.oup.com/ecco-jcc/article/6/4/419/426010?login=true
8. Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting - PubMed. Accessed February 18, 2022. https://pubmed-ncbi-nlm-nih-gov.libux.utmb.edu/31839434/
9. Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010 - PubMed. Accessed February 18, 2022. https://pubmed-ncbi-nlm-nih-gov.libux.utmb.edu/20577159/
10. Hasan T, Au E, Chen S, Tong A, Wong G. Screening and prevention for latent tuberculosis in immunosuppressed patients at risk for tuberculosis: a systematic review of clinical practice guidelines.BMJ Open . 2018;8(9):e022445. doi:10.1136/bmjopen-2018-022445
11. Subramanian AK, Theodoropoulos NM, Infectious Diseases Community of Practice of the American Society of Transplantation. Mycobacterium tuberculosis infections in solid organ transplantation: Guidelines from the infectious diseases community of practice of the American Society of Transplantation. Clin Transplant . 2019;33(9):e13513. doi:10.1111/ctr.13513
12. Redelman-Sidi G, Sepkowitz KA. IFN-γ Release Assays in the Diagnosis of Latent Tuberculosis Infection among Immunocompromised Adults.Am J Respir Crit Care Med . 2013;188(4):422-431. doi:10.1164/rccm.201209-1621CI
13. Uzorka JW, Wallinga J, Kroft LJM, Ottenhoff THM, Arend SM. Radiological Signs of Latent Tuberculosis on Chest Radiography: A Systematic Review and Meta-Analysis. Open Forum Infect Dis . 2019;6(7):ofz313. doi:10.1093/ofid/ofz313
14. Malaviya AN, Kapoor S, Garg S, et al. Preventing Tuberculosis Flare in Patients with Inflammatory Rheumatic Diseases Receiving Tumor Necrosis Factor-α Inhibitors in India — An Audit Report. The Journal of Rheumatology . 2009;36(7):1414-1420. doi:10.3899/jrheum.081042
15. Sterling TR, Njie G, Zenner D, et al. Guidelines for the treatment of latent tuberculosis infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020. American Journal of Transplantation . 2020;20(4):1196-1206. doi:10.1111/ajt.15841
16. Amin I, Idrees M, Awan Z, Shahid M, Afzal S, Hussain A. PCR could be a method of choice for identification of both pulmonary and extra-pulmonary tuberculosis. BMC Res Notes . 2011;4:332. doi:10.1186/1756-0500-4-332